ASX Stock

At Trader Dealer we understand the importance of information. You can use our handy company information finder to get key fundamental data about any company listed on the ASX.

Simply enter the stock code or the name of the company you are interested in for ASX share price information, company size, research analyst forecast, share and financial ratios, as well as a business and financial summary.

Don’t know the ASX code of the stock you want? Just click on the letter below for a full alphabetical listing.


Enter ASX Stock Code

Bookmark Page !



View all Companies by Letters

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 


 
 

Novogen Limited
Industry Group: Biotechnology / Medical Research - Biotechnology

Trade Online with Trader Dealer

Sorry, No Chart Available.

Business Summary
Novogen Limited is engaged in pharmaceutical research and development, and marketing of consumer healthcare products. The Company has three segments: Drug Development, Oncology Drug Program and Wound Healing. Drug Development includes the discovery of new compounds and the early stage screening for bioactivity of such compounds through both in vivo and in vitro testing. Oncology Drug Program involves the development of selected oncology drug candidates, which have indicated bioactivity against cancer cells through clinical trial programs to assess safety and efficacy. Wound Healing is a separate technology based on Beta-1 Glucan to aid in the management of wounds. The Company’s clinical development program run through Novogen’s subsidiaries Marshall Edwards, Inc. (MEI) and Glycotex, Inc. (Glycotex). In August 2011, the Company sold its consumer products business to Pharm-a-Care Laboratories Pty Limited.

Financial Summary
BRIEF: For the Fiscal year ended 30 June 2011, Novogen Limited's revenues increased 14% to A$2M. Net loss decreased 38% to A$8M. Revenues reflect increased income from Consumer Business division and higher other revenue. lower loss also reflects a fall in selling & distribution expenses, lower advertising expenses, a decrease in research & development expense, a fall in depreciation expenses and decreased in net currency losses.

Business Address
e

140 Wicks Road
NORTH RYDE, NSW 2113
Phone: 61-2-98780088
Fax: 61-2-98780055
http://www.novogen.com/

ASX Share Price Information
Current Price 0.092
Current Price Date 22/02/2012
52 Week Hi/Low 0.46 - 0.09
Avg Volume Last ten Days 0.06
ASX Company Sizing
Market Cap 9.40
Revenues 3.28
EBITDA -10.84
Net Income -7.97
Number of Employees 21
Enterprise Value 3.28
Research Analyst Forecast
Consensus Recommendation -
Target Price -
LT Growth Rate -
Projected P/E -
Sales -
EPS -
Profit -
DPS -
Share Ratios
EPS -0.07799
RPS 0.01983
BV per Share 0.04141
Cash per Share 0.05988
Cashflow per Share -0.10637
Cashflow per Share 0.00000
Financial Ratios
Gross Margin -
ROE -103.32080
Price/Sales 4.63979
P/E -
P/Book 2.22170